Editorial Office of EpiNorth Journal encourages authors before submitting their manuscripts read carefully following Guidelines for Authors. If additional questions arise please address to email@example.com.
Scope of EpiNorth Journal
EpiNorth Journal is aimed for the audience interested in the surveillance and control of communicable diseases in Baltic States, Nordic countries and the Russian Federation (Northern Europe). It covers news of recent outbreaks in the Northern European area, annual surveillance data, reports of public health policies, emerging infections and other topics in the field of communicable disease epidemiology. Review articles, case reports and comments covering different aspects of infectious disease control and epidemiology are invited for considering for publication.
We accept for consideration for publication original manuscripts (not previously published elsewhere) and manuscripts for secondary publication if topic is within scope of EpiNorth Journal.
Manuscripts should be submitted to the Editorial Office in either English or Russian (or both) in Word or Adobe format to the following e-mail address: firstname.lastname@example.org.
Submission should include cover letter, stating manuscripts relevance to EpiNorth Journal, name of the co-authors, full contact-details of the corresponding author (e-mail, fax, telephone number and correspondence address).
Structure of the paper
Submitted manuscript should follow the standard main structure of a scientific paper: Abstract, Introduction, Methods, Results and Discussion (IMRaD). The IMRAD structure is recommended in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication" issued by the International Committee of Medical Journal Editors (the Vancouver Group), which EpiNorth Journal follows.
Short description of the main elements of the article:
Abstract(200-250 words) should introduce the manuscript followed by keywords (maximum of 5 words). Abstract is an essence of the article describing main methods explored, main results and conclusions.
This comprises one or several paragraphs which outline the research question and its significance within the topic being discussed, making it clear what the relevance of the research question and topic are for readers of the paper.
Describes how you gathered the information. What laboratory methods did you use for the verification of the diagnosis? What other laboratory measurements did you do? What analytical study design did you use? What kind of measurements of association (odds ratio, relative risk) did you use? How did you select you study population? Who did you interview? What statistical methods did you use? What are the sources of information?
What did you find based on the methods used in your study? Report results and do not try to interpret them in this section. Support your results with tables and graphs.
What do the findings described under "Results" section mean? How your findings relate to what other researchers had been found? Do your results answer your study question and research hypothesis? What are the limitations and strengths of your results? Structure of building the discussion is well described by Docherty and Smith (see: BMJ 1999;318:1224-1225 (8 May) and recommended for the authors.
List of references
Normally a maximum of 20 references should complete the manuscript following the EpiNorth journal style.
More on how to structure the article you can read in overview of the "IMRAD format" from the Writing Center of the University of Wisconsin.
Length of the paper
Outbreak news, presentations, case reports and other short communications should be between 400 and 1000 words in length (including references), and may be unstructured without headings.
Short original papers are likely to be 1500 to 2000 words in length (including references), and should follow IMRaD structure (see Structure of the paper). Exceptions can be made after discussion with managing editor.
Style of the paper
The manuscript should be submitted with 1,5 spaced text in Times New Roman with 10 font size.
For the selection of the appropriate keywords of the manuscript please refer to Medical Subject Headings (MeSH) at www.nlm.nih.gov/mesh.
The text should usually follow the structure of Introduction, Materials and Method, Results and Discussion (see Structure of the paper). Headings and subheadings for different sections of the paper should be clearly indicated and numbered. Ensure that all figures and tables are mentioned in the text, and that all references are cited in number order.
Abbreviations should be avoided as much as possible and defined when first used. Abbreviations should be used consistently throughout the text. Tables should be easy to understand with clear title, submitted in Excel or Word format. Figures can be submitted in JPEG, GIF, Excel or PowerPoint format, and used only if a visual image will enhance or complement the text. Information from tables or figures should not be repeated in the text. The original data used for figures and tables should be enclosed.
The Editor of EpiNorth Journal reserves the right to suggest editing of the manuscript for purposes of clarity and consistence with the style of the Journal.
References should give the names and initials of the first three authors before "et al", the title of the article, journal name, year of publication, volume number, and the first and last page numbers of articles. References must be numbered in the same order that they appear in the text. The titles of journals in the reference list should be abbreviated according to Medical Subject Headings (www.nlm.nih.gov/mesh)
All original papers submitted to EpiNorth Journal will be peer-reviewed by Editors. Decision on rejection or further external peer-review is taken within 14 days. Criteria used for acceptance/rejection are: originality, structure/clarity, audience oriented, and validity. When a manuscript is returned for revision prior to final acceptance, the revised version must be submitted after 1 month at maximum after the author's receipt of the reviewer's comments. The corresponding author should contact all coauthors and coordinate corrections of the manuscript among them. The corresponding author should manage communications with the journal.
EpiNorth considers manuscripts that have not been previously published and are not being simultaneously considered for publication elsewhere. If a contribution is accepted for publishing in EpiNorth, it may later be freely republished if EpiNorth Journal is fully acknowledged and the Editors and authors are informed and agreed.
After special agreement, articles that have been already published in other journals, newsletters or other periodicals might be re-published in EpiNorth. The agreement must be obtained from the Editor of the original publication and authors.
EpiNorth Journals policy on Authors’ contribution
EpiNorth Journal requires statement from the first author of the paper to state individual contribution of co-authors to the scientific work described in the manuscript.This will avoid possible misunderstanding of authorship and provide transparency of the scientific work done to produce a manuscript. The corresponding author is responsible for preparing such document and for managing all communication between the journal and all co-authors, before and after publication. Any changes to the author list after submission, such as a change in the order of the authors, or the deletion or addition of authors, needs to be approved by a signed letter from every author.
Checklist before submission:
1. Cover letter
2. Manuscript file (following IMRaD structure, containing Abstract and List of References)
4. Word count
5. Tables files (Excel, Word)
6. Figure files (jpeg, gif, Excel, PowerPoint)
7. Authors’ contribution
8. Contact details of the corresponding author